Food reactions are not always allergies. A Paris expert outlined how timing, symptoms, and testing help clinicians separate intolerance from true immune-mediated disease. Medscape News Europe
Tag: News
Branded Bevacizumab: Retina Breakthrough or Bankbuster?
Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits in may be a matter of cost and acceptance. Medscape Medical News
Medicare Is Paying Less for Cataract Surgery
Medicare pays doctors about $520 for a standard cataract procedure, down about 20% in the past decade. KFF Health News
France Reports New Local Arboviral Infections in 2026
Imported arboviral infections are climbing in France, with locally acquired cases now reported. Clinicians are urged to spot early clues and report suspected cases fast. Medscape News Europe
EyePoint’s Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its… Reuters Health Information
One Broken Pathway Drives Aging. Scientists Aim to Fix It
A decline in the functioning of the cellular cleanup pathway drives disease across nearly every organ. Now drugs that restore it are heading toward the clinic. Medscape Medical News
Eye Doctors Urge Caution Ahead of UK Solar Eclipse
On Wednesday evening, the moon will cover up to 96% of the sun in the UK’s deepest eclipse since 1999. Medscape News UK
Pediatric Eye Emergencies: 4 Red Flags Not to Miss
Experts review four pediatric eye emergencies and the warning signs requiring urgent referrals to help prevent permanent vision loss and identify life-threatening disease. Medscape News Europe
The Unknowns in Your Salary Plan Could Cost You
Doctors often overlook or misunderstand important metrics and incentives in their compensation plan, which can drag down their income. Medscape Medical News
Who ‘Owns’ Long-Term TED Management in the Biologic Era?
Targeted biologics and multidisciplinary care are reshaping the management of patients with thyroid eye disease. But who should be leading this care and how? Medscape would like to hear from you about how often you see TED, your biggest clinical challe…
Better Optometry Access Could Cut 400,000 A&E visits
Analysis finds up to 78% of eye-related A&E visits could be managed by community optometrists instead. Press Association
Statins Reduce Retinal Detachment Repair Failures
People taking statins have about half the rate of sight-threatening proliferative vitreoretinopathy and need another operation after surgery to fix retinal detachment. Medscape Medical News
Statins Tied to Fewer Failures After Retina Fixes
People taking statins have about half the rate of sight-threatening proliferative vitreoretinopathy and need another operation after surgery to fix retinal detachment. Medscape Medical News
Photoprotection in High-Risk Patients
High-risk patients need more than sunscreen alone, as new evidence highlights tailored photoprotection strategies for transplant recipients, xeroderma pigmentosum, albinism, workers, and lupus. Medscape News Global
Infantile Hemangiomas: When Is a PHACE Workup Warranted?
Most congenital hemangiomas on the skin are managed with standard therapies, but an expert specified lesions that are at risk for systemic complications to provide guidance for rapid intervention. Medscape Medical News
US FDA Approves Outlook Therapeutics’ Eye Disease Drug
Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for a type of eye disease that can cause vision loss. Reuters Health Information
Gene Therapy Delivers Sustained Retinal Protection
People with age-related macular degeneration maintain vision and cut their need for supplemental injections by 90% 5 years after receiving gene therapy. Medscape Medical News
Faricimab Reduces Shots, Improves Vision for Retinal Disease
In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs. Medscape Medical News
Delays Harmless for Most Macular Degeneration Patients
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss. Medscape Medical News
Home Eye Scans Best Suited for High-Cost Retina Meds
Home-based optical tomography may only be cost-effective for patients on more expensive treatments. Medscape Medical News